GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ScandiDos AB (OSTO:SDOS) » Definitions » EV-to-EBITDA

ScandiDos AB (OSTO:SDOS) EV-to-EBITDA : -58.29 (As of Jun. 14, 2024)


View and export this data going back to 2014. Start your Free Trial

What is ScandiDos AB EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, ScandiDos AB's enterprise value is kr99.91 Mil. ScandiDos AB's EBITDA for the trailing twelve months (TTM) ended in Jan. 2024 was kr-1.71 Mil. Therefore, ScandiDos AB's EV-to-EBITDA for today is -58.29.

The historical rank and industry rank for ScandiDos AB's EV-to-EBITDA or its related term are showing as below:

OSTO:SDOS' s EV-to-EBITDA Range Over the Past 10 Years
Min: -61.95   Med: -13.47   Max: 2031.4
Current: -58.28

During the past 13 years, the highest EV-to-EBITDA of ScandiDos AB was 2031.40. The lowest was -61.95. And the median was -13.47.

OSTO:SDOS's EV-to-EBITDA is ranked worse than
100% of 480 companies
in the Medical Devices & Instruments industry
Industry Median: 15.755 vs OSTO:SDOS: -58.28

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-14), ScandiDos AB's stock price is kr1.79. ScandiDos AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jan. 2024 was kr-0.105. Therefore, ScandiDos AB's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


ScandiDos AB EV-to-EBITDA Historical Data

The historical data trend for ScandiDos AB's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ScandiDos AB EV-to-EBITDA Chart

ScandiDos AB Annual Data
Trend Apr14 Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only -7.45 -9.97 60.11 -32.92 -31.66

ScandiDos AB Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -17.30 -31.66 -45.13 -33.13 -53.03

Competitive Comparison of ScandiDos AB's EV-to-EBITDA

For the Medical Devices subindustry, ScandiDos AB's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ScandiDos AB's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, ScandiDos AB's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where ScandiDos AB's EV-to-EBITDA falls into.



ScandiDos AB EV-to-EBITDA Calculation

ScandiDos AB's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=99.906/-1.714
=-58.29

ScandiDos AB's current Enterprise Value is kr99.91 Mil.
ScandiDos AB's EBITDA for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-1.71 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ScandiDos AB  (OSTO:SDOS) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

ScandiDos AB's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=1.79/-0.105
=At Loss

ScandiDos AB's share price for today is kr1.79.
ScandiDos AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-0.105.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


ScandiDos AB EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of ScandiDos AB's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


ScandiDos AB (OSTO:SDOS) Business Description

Traded in Other Exchanges
Address
Uppsala Science Park, Uppsala, SWE, S-751 83
ScandiDos AB is a Sweden based company involved in providing Radiation Therapy. It provides measurement systems and software that are designed for QA and validation of treatments that are being implemented in clinics around the world.

ScandiDos AB (OSTO:SDOS) Headlines

No Headlines